End of the line for cannabinoid receptor 1 as an anti-obesity target? An opinion

被引：13
作者：
Bifulco, Maurizio [1 ]
Pisanti, Simona [1 ]
机构：
[1] Univ Salerno, Dept Pharmaceut Sci, Salerno, Italy
来源：
NATURE REVIEWS DRUG DISCOVERY | 2009年 / 8卷 / 07期
关键词：
D O I：
10.1038/nrd2775-c1
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
[No abstract available]
引用
收藏
页码：594 / 594
页数：1
相关论文
共 6 条
  • [1] Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1)
    Barrero, FJ
    Ampuero, I
    Morales, B
    Vives, F
    del Castillo, JDL
    Hoenicka, J
    Yébenes, JG
    [J]. PHARMACOGENOMICS JOURNAL, 2005, 5 (02) : 135 - 141
  • [2] Overweight, obesity, and cancer risk
    Bianchini, F
    Kaaks, R
    Vainio, H
    [J]. LANCET ONCOLOGY, 2002, 3 (09) : 565 - 574
  • [3] Endocannabinoids in endocrine and related tumours
    Bifulco, Maurizio
    Malfitano, Anna Maria
    Pisanti, Simona
    Laezza, Chiara
    [J]. ENDOCRINE-RELATED CANCER, 2008, 15 (02) : 391 - 408
  • [4] Rimonabant: Just an Antiobesity drug? Current evidence on its pleiotropic effects
    Bifulco, Maurizio
    Grimaldi, Claudia
    Gazzerro, Patrizia
    Pisanti, Simona
    Santoro, Antonietta
    [J]. MOLECULAR PHARMACOLOGY, 2007, 71 (06) : 1445 - 1456
  • [5] End of the line for cannabinoid receptor 1 as an anti-obesity target?
    Jones, Dan
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (12) : 961 - 962
  • [6] Antiangiogenic activity of the endocannabinoid anandamide: Correlation to its tumor-suppressor efficacy
    Pisanti, Simona
    Borselli, Cristina
    Oliviero, Olimpia
    Laezza, Chiara
    Gazzerro, Patrizia
    Bifulco, Mauriz
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2007, 211 (02) : 495 - 503
1